The benefits of PCNL combined with ureterorenoscopy compared to isolated PCNL in urolithiasis ( PRECISE ): a multicentre randomised controlled trial protocol
BJU International · 2026
DOI: 10.1111/bju.70008 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift BJU International, 2026. Verfasst von Chris A Suijker und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands. Hauptthemen laut MEDLINE: Nephrolithotomy, Percutaneous, Ureteroscopy, Kidney Calculi, Urolithiasis. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Background Percutaneous nephrolithotomy (PCNL) often fails to achieve complete stone clearance with a single procedure. Residual fragments, irrespective of size, are associated with increased stone‐related morbidity and a higher likelihood of re‐intervention. Endoscopic combined intrarenal surgery (ECIRS), which integrates PCNL with retrograde ureterorenoscopy, may improve stone‐free rates and reduce morbidity. However, given the potential for increased risks and greater resource utilisation, a comprehensive randomised controlled trial is warranted. The ‘PRECISE’ trial is designed to compare ECIRS and PCNL in terms of efficacy, safety, stone‐related morbidity, and resource utilisation. Study Design The PRECISE is a prospective, non‐blinded, randomised, parallel‐group, multicentre interventional trial involving patients eligible for percutaneous kidney stone surgery. Patients will be randomised in a 1:1 ratio to undergo either ECIRS or standard PCNL. Endpoints The primary endpoint is the Grade A (0 mm) stone‐free rate on postoperative computed tomography (CT) at 4 weeks. Secondary radiological endpoints include Grade B (≤2 mm) and Grade C (≤4 mm) stone‐free rates at 4 weeks, stone volume reduction, 1‐year stone‐free rates, and radiation exposure. Additional outcomes include complications, operative duration, stone‐related events (SREs), health‐related quality of life (HRQoL), cost differences, cost‐effectiveness and environmental impact, assessed up to 5 years postoperatively. Patients and Methods Adults (aged ≥18 years) eligible for percutaneous kidney stone surgery, where retrograde access is feasible, will be recruited. The main exclusion criteria comprise papillary calcifications, renal transplant procedures, and (suspected) pregnancy. A total of 350 patients (175 per arm) will be recruited. Follow‐up includes CT imaging with clinical consultations at 4 weeks and 1 year to evaluate radiological outcomes, complications, SREs, and HRQoL. Telephone interviews at 3 and 5 years will assess long‐term SREs and HRQoL. We aim to retrospectively evaluate cost differences, cost‐effectiveness, and environmental impact. Trial Registration The PRECISE study: an investigation into combined kidney stone surgery, Dutch Trial Registry, NL‐009577.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Urology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.
- Department of Urology, Ziekenhuisgroep Twente (Hospital Group Twente), Almelo, The Netherlands.
- Department of Urology, Isala Ziekenhuis (Isala Clinics), Zwolle, The Netherlands.
- Department of Urology, Martini Ziekenhuis (Martini Hospital), Groningen, The Netherlands.
- Department of Health Sciences, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.
- Department of Epidemiology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.
ORCID-Profile: Chris A Suijker, Riemer A Kingma, Inge M van Oort, Stijn Roemeling
Zitieren
APA
Suijker, C. A., Kingma, R. A., Bakker, D., Goossens, W., Poerink, J., van Asselt, A. D. I., van Oort, I. M., Roemeling, S., & ROUND‐PRECISE study group (2026). The benefits of PCNL combined with ureterorenoscopy compared to isolated PCNL in urolithiasis ( PRECISE ): a multicentre randomised controlled trial protocol. BJU International. https://doi.org/10.1111/bju.70008
Vancouver
Suijker CA, Kingma RA, Bakker D, Goossens W, Poerink J, van Asselt ADI, et al. The benefits of PCNL combined with ureterorenoscopy compared to isolated PCNL in urolithiasis ( PRECISE ): a multicentre randomised controlled trial protocol. BJU International. 2026. doi:10.1111/bju.70008
BibTeX
@article{Suijker2026,
author = {Suijker, Chris A and Kingma, Riemer A and Bakker, Dirk and Goossens, Ward and Poerink, Jaap and van Asselt, Antoinette D I and van Oort, Inge M and Roemeling, Stijn and ROUND‐PRECISE study group, ROUND‐PRECISE study group},
title = {The benefits of PCNL combined with ureterorenoscopy compared to isolated PCNL in urolithiasis ( PRECISE ): a multicentre randomised controlled trial protocol},
journal = {BJU International},
year = {2026},
doi = {10.1111/bju.70008}
}
EUVIMED